tradingkey.logo

ReShape Lifesciences Inc

RSLS

2.490USD

0.000
Market hours ETQuotes delayed by 15 min
13.25KMarket Cap
LossP/E TTM

ReShape Lifesciences Inc

2.490

0.000
More Details of ReShape Lifesciences Inc Company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Company Info
Ticker SymbolRSLS
Company nameReShape Lifesciences Inc
IPO dateOct 06, 2016
CEOMr. Paul F. Hickey
Number of employees17
Security typeOrdinary Share
Fiscal year-endOct 06
Address1001 Calle Amanecer
CitySAN CLEMENTE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92673
Phone19494296680
Websitehttps://www.reshapelifesciences.com/obalon/
Ticker SymbolRSLS
IPO dateOct 06, 2016
CEOMr. Paul F. Hickey
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas (Tom) Stankovich
Mr. Thomas (Tom) Stankovich
Chief Financial Officer
Chief Financial Officer
16.00
--
Mr. Paul F. Hickey
Mr. Paul F. Hickey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Arda M. Minocherhomjee ,Ph.D.
Arda M. Minocherhomjee ,Ph.D.
Independent Director
Independent Director
--
--
Michael Miller
Michael Miller
IR Contact Officer
IR Contact Officer
--
--
Mr. Dan W. Gladney
Mr. Dan W. Gladney
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas (Tom) Stankovich
Mr. Thomas (Tom) Stankovich
Chief Financial Officer
Chief Financial Officer
16.00
--
Mr. Paul F. Hickey
Mr. Paul F. Hickey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Arda M. Minocherhomjee ,Ph.D.
Arda M. Minocherhomjee ,Ph.D.
Independent Director
Independent Director
--
--
Michael Miller
Michael Miller
IR Contact Officer
IR Contact Officer
--
--
Mr. Dan W. Gladney
Mr. Dan W. Gladney
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
No Data
By RegionUSD
Name
Revenue
Proportion
United States
931.00K
83.65%
Europe
98.00K
8.81%
Australia
78.00K
7.01%
Rest of World
6.00K
0.54%
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
L1 Capital Global Opportunities Master Fund Ltd.
9.85%
Leonite Fund I LP
0.34%
FirstFire Global Opportunities Fund LLC
0.34%
Bigger Capital Funds, LP
0.27%
District 2 Capital LP
0.27%
Other
88.94%
Shareholders
Shareholders
Proportion
L1 Capital Global Opportunities Master Fund Ltd.
9.85%
Leonite Fund I LP
0.34%
FirstFire Global Opportunities Fund LLC
0.34%
Bigger Capital Funds, LP
0.27%
District 2 Capital LP
0.27%
Other
88.94%
Shareholder Types
Shareholders
Proportion
Corporation
10.56%
Hedge Fund
0.60%
Investment Advisor
0.11%
Individual Investor
0.06%
Investment Advisor/Hedge Fund
0.02%
Other
88.64%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
34
270.94K
11.36%
+258.61K
2025Q1
42
35.95K
1.85%
+23.58K
2024Q4
36
92.62K
3.05%
+33.67K
2024Q3
40
51.79K
41.95%
-7.67K
2024Q2
37
52.29K
38.14%
-3.61K
2024Q1
40
50.20K
37.62%
-6.41K
2023Q4
40
53.11K
38.38%
+43.81K
2023Q3
41
10.13K
39.05%
+5.49K
2023Q2
42
5.11K
36.27%
+1.18K
2023Q1
51
5.76K
66.25%
+4.13K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
L1 Capital Global Opportunities Master Fund Ltd.
235.00K
9.85%
+235.00K
--
Jun 09, 2025
Leonite Fund I LP
8.00K
0.34%
+8.00K
--
Feb 18, 2025
FirstFire Global Opportunities Fund LLC
8.00K
0.34%
+8.00K
--
Feb 18, 2025
Bigger Capital Funds, LP
6.40K
0.27%
+6.40K
--
Feb 18, 2025
District 2 Capital LP
6.40K
0.27%
+6.40K
--
Feb 18, 2025
UBS Financial Services, Inc.
2.23K
0.09%
+1.52K
+214.99%
Mar 31, 2025
Schneid (Yair)
1.50K
0.06%
-201.00
-11.84%
Sep 23, 2024
Dominion Capital LLC
1.01K
0.04%
--
--
Feb 18, 2025
Renaissance Technologies LLC
652.00
0.03%
+652.00
--
Mar 31, 2025
Geode Capital Management, L.L.C.
435.00
0.02%
+435.00
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Date
Type
Ratio
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Jun 15, 2021
Merger
3<1
Jun 15, 2021
Merger
3<1
View more
KeyAI